Literature DB >> 20566084

Efficacy of carotid artery stenting.

H Sato1, K Matsuo, H Miwa, T Hirohata, M Kohno, Y Mayanagi, N Kato, T Takigawa, T Tsunoda, E Kobayashi.   

Abstract

SUMMARY: Carotid Artery Stenting(CAS) was performed for 51 lesions in 46 patients for almost clinically symptomatic stenotic (> 70%)lesions of cervical carotid arteries. The lesions involved the contralateral occlusion cases in eight cases, the bilateral stenotic cases in six cases and the ipsilateral internal carotid artery stenotic cases in two cases. In all cases, endovascular technique was performed from a transfemoral approach under local anesthesia primarily. Under systemic heparinization, CAS was performed using a selfexpanding stent system. For the pre-stenting and post-stenting dilatation, percutaneous transluminal angioplasty (PTA) balloon catheters were used. The balloon was inflated up to the pressure of six to ten atoms for 20 to 30 seconds.After CAS, stenotic lesion dilated successfully in all cases (0-20% residual stenosis; mean, 5.5%) even if in the case of the contra-lateral occlusion cases, more than 90% severe stenotic cases, and the tortuous artery cases. The cerebral protection system was always used, mainly distal blocking balloon type. Only one symptomatic complication occurred after CAS. Follow-up ultrasonic carotid echogram was performed in 30 cases.No cases showed restenosis (more than 50% restenosis). Clinical follow up was performed in all cases for one to 41 months (mean, 15.2 months) and no clinical deterioration such as TIA or stroke occurred. CAS is technically feasible and can be performed with relatively low morbidity even if complicated stenotic cases. It may be useful, but the increase the number of patients and the long-term follow-up are necessary to evaluate the safety and usefulness of this method.

Entities:  

Year:  2007        PMID: 20566084      PMCID: PMC3345473          DOI: 10.1177/15910199070130S113

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  6 in total

1.  Carotid artery stenting: technical considerations.

Authors:  J J Vitek; G S Roubin; N Al-Mubarek; G New; S S Iyer
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

Review 2.  Early outcome of carotid angioplasty and stenting with and without cerebral protection devices: a systematic review of the literature.

Authors:  Andreas Kastrup; Klaus Gröschel; Hilmar Krapf; Bernhard R Brehm; Johannes Dichgans; Jörg B Schulz
Journal:  Stroke       Date:  2003-02-13       Impact factor: 7.914

3.  Carotid artery stenting protected with an emboli containment system.

Authors:  Patrick L Whitlow; Pedro Lylyk; Hugo Londero; Oscar A Mendiz; Klaus Mathias; Horst Jaeger; Juan Parodi; Claudio Schönholz; Jose Milei
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Global experience in cervical carotid artery stent placement.

Authors:  M H Wholey; M Wholey; K Mathias; G S Roubin; E B Diethrich; M Henry; S Bailey; P Bergeron; G Dorros; G Eles; P Gaines; C R Gomez; B Gray; J Guimaraens; R Higashida; D S Ho; B Katzen; A Kambara; V Kumar; J C Laborde; M Leon; M Lim; H Londero; J Mesa; A Musacchio; S Myla; S Ramee; A Rodriquez; K Rosenfield; N Sakai; F Shawl; H Sievert; G Teitelbaum; J G Theron; P Vaclav; C Vozzi; J S Yadav; S I Yoshimura
Journal:  Catheter Cardiovasc Interv       Date:  2000-06       Impact factor: 2.692

5.  Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement.

Authors:  J G Theron; G G Payelle; O Coskun; H F Huet; L Guimaraens
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

6.  Protected carotid-artery stenting versus endarterectomy in high-risk patients.

Authors:  Jay S Yadav; Mark H Wholey; Richard E Kuntz; Pierre Fayad; Barry T Katzen; Gregory J Mishkel; Tanvir K Bajwa; Patrick Whitlow; Neil E Strickman; Michael R Jaff; Jeffrey J Popma; David B Snead; Donald E Cutlip; Brian G Firth; Kenneth Ouriel
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.